Nan Wu

1.1k total citations
44 papers, 734 citations indexed

About

Nan Wu is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Nan Wu has authored 44 papers receiving a total of 734 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Pharmacology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Nan Wu's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Receptor Mechanisms and Signaling (5 papers). Nan Wu is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Receptor Mechanisms and Signaling (5 papers). Nan Wu collaborates with scholars based in United States, China and Australia. Nan Wu's co-authors include Hongtao Yu, H. E. Amandus, Guohua An, Zhiwei Feng, Xiang‐Qun Xie, Ross Warrington, Guang X. Chen, Zhejian Ji, Weihua Zeng and Weiwei Lin and has published in prestigious journals such as Genes & Development, The EMBO Journal and Cancer Research.

In The Last Decade

Nan Wu

44 papers receiving 722 citations

Peers

Nan Wu

APM

SURGE

Tomohiro Yamamoto Japan

Rajko Igić United States

Francisco Vara Spain

Jennifer A. Fraser United Kingdom

Richard Robinson United States

Robert J. Capetola United States

Cong Xu China

Raihan Mohammed United Kingdom

Jiyeon Park South Korea

William P. Feeney United States

Tomohiro Yamamoto Japan

Nan Wu

180 ×0.5

51 ×0.6

36 ×0.5

81 ×1.1

APM

105 ×1.7

SURGE

Citations per year, relative to Nan Wu Nan Wu (= 1×) peers Tomohiro Yamamoto

Countries citing papers authored by Nan Wu

Since Specialization

Citations

This map shows the geographic impact of Nan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Wu more than expected).

Fields of papers citing papers by Nan Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Wu. The network helps show where Nan Wu may publish in the future.

Co-authorship network of co-authors of Nan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Nan Wu. A scholar is included among the top collaborators of Nan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nan Wu. Nan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Kaixin, Qing Zhu, Wen Liu, et al.. (2025). Mitochondrial apoptosis in response to cardiac ischemia-reperfusion injury. Journal of Translational Medicine. 23(1). 125–125. 2 indexed citations

Zhang, Feng, Yan Wu, Nan Wu, et al.. (2024). Elevated cerebrospinal fluid biomarkers of neuroinflammation and neuronal damage in essential hypertension with secondary insomnia: Implications for Alzheimer’s disease risk. Brain Behavior and Immunity. 125. 158–167. 2 indexed citations

Tao, Jun, Shuaibing Liu, Ying Zhao, et al.. (2023). Pharmacokinetics, pharmacodynamics, and safety of ciprofol emulsion in Chinese subjects with normal or impaired renal function. Frontiers in Pharmacology. 14. 1260599–1260599. 10 indexed citations

Wu, Nan, David A. Katz, & Guohua An. (2023). Population Target-Mediated Pharmacokinetic/Pharmacodynamic Modeling to Evaluate SPI-62 Exposure and Hepatic 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD-1) Inhibition in Healthy Adults. Clinical Pharmacokinetics. 62(9). 1275–1288. 2 indexed citations

Wu, Nan & Guohua An. (2023). A Quantitative Systems Pharmacology Model of the Incretin Hormones GIP and GLP1, Glucagon, Glucose, Insulin, and the Small Molecule DPP-4 Inhibitor, Linagliptin. Journal of Pharmaceutical Sciences. 113(1). 278–289. 3 indexed citations

Wang, Kun, Yuting Yang, Mengyue Hu, et al.. (2023). Population pharmacokinetic/pharmacodynamic modeling and exposure-response analysis of ciprofol in the induction and maintenance of general anesthesia in patients undergoing elective surgery: A prospective dose optimization study. Journal of Clinical Anesthesia. 92. 111317–111317. 17 indexed citations

Wu, Nan, et al.. (2020). Slow-Release Drug–Drug Cocrystals of Oxaliplatin with Flavonoids: Delaying Hydrolysis and Reducing Toxicity. Crystal Growth & Design. 21(1). 75–85. 27 indexed citations

Wu, Nan & Guohua An. (2020). Incorporating Pharmacological Target-Mediated Drug Disposition (TMDD) in a Whole-Body Physiologically Based Pharmacokinetic (PBPK) Model of Linagliptin in Rat and Scale-up to Human. The AAPS Journal. 22(6). 125–125. 7 indexed citations

Wu, Nan, Bruce D. Hammock, Kin Sing Stephen Lee, & Guohua An. (2020). Simultaneous Target-Mediated Drug Disposition Model for Two Small-Molecule Compounds Competing for Their Pharmacological Target: Soluble Epoxide Hydrolase. Journal of Pharmacology and Experimental Therapeutics. 374(1). 223–232. 10 indexed citations

10.

Wu, Nan, et al.. (2019). Layer-by-layer assembly for steering the survival and immunogenicity of RPE cells In Vitro and In Vivo. Investigative Ophthalmology & Visual Science. 60(9). 1924–1924. 1 indexed citations

11.

Wang, Yuanqiang, Weiwei Lin, Nan Wu, et al.. (2019). Structural insight into the serotonin (5-HT) receptor family by molecular docking, molecular dynamics simulation and systems pharmacology analysis. Acta Pharmacologica Sinica. 40(9). 1138–1156. 36 indexed citations

12.

Wu, Nan, et al.. (2019). Insight of Captagon Abuse by Chemogenomics Knowledgebase-guided Systems Pharmacology Target Mapping Analyses. Scientific Reports. 9(1). 2268–2268. 20 indexed citations

13.

Wu, Nan, et al.. (2016). [Association between sense of coherence and occupational stress of workers in modern service industry in Shanghai, China].. PubMed. 34(10). 731–736. 5 indexed citations

14.

Gao, Qiang, et al.. (2015). Protective effects of dexmedetomidine on intestinal ischemia-reperfusion injury. Experimental and Therapeutic Medicine. 10(2). 647–652. 28 indexed citations

15.

Fattah, Farjana, Kodai Hara, Kazi R. Fattah, et al.. (2014). The Transcription Factor TFII-I Promotes DNA Translesion Synthesis and Genomic Stability. PLoS Genetics. 10(6). e1004419–e1004419. 34 indexed citations

16.

Menéndez, Cammie Chaumont, et al.. (2014). Cities with camera-equipped taxicabs experience reduced taxicab driver homicide rates: United States, 1996–2010. Crime Science. 3(1). 6 indexed citations

17.

Amandus, H. E., et al.. (2013). Effectiveness of Taxicab Security Equipment in Reducing Driver Homicide Rates. American Journal of Preventive Medicine. 45(1). 1–8. 11 indexed citations

18.

Wu, Nan & Hongtao Yu. (2012). The Smc complexes in DNA damage response. Cell & Bioscience. 2(1). 5–5. 96 indexed citations

19.

Wu, Nan, Xiangduo Kong, Zhejian Ji, et al.. (2012). Scc1 sumoylation by Mms21 promotes sister chromatid recombination through counteracting Wapl. Genes & Development. 26(13). 1473–1485. 70 indexed citations

20.

Liang, Chun, et al.. (2006). Ecdysone induces transcription and amplification in Sciara coprophila DNA puff II/9A. Developmental Biology. 299(1). 151–163. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact